MTND1P33

Across TCGA pan-cancer cohorts, MTND1P33 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MTND1P33 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher MTND1P33 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND1P33 expression acts as an unfavorable survival marker, although some lineages such as BLCA and ESCA show a favorable association.

READ, SKCM, and STAD are the cancer types where MTND1P33 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.112	0.845	.001	36	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	24	view →
STAD	OS	Tertile	IV	0.177	0.578	.024	18	view →
PCPG	OS	Tertile	All	0.539	0.848	.013	18	view →
BRCA	OS	Tertile	III,IV	0.140	0.548	.013	12	view →
PRAD	DFS	Tertile	All	0.520	0.778	.004	12	view →
ACC	OS	Tertile	II,III,IV	0.468	0.802	.015	9	view →
GBM	OS	Tertile	All	0.089	0.415	.021	9	view →
BLCA	DFS	Tertile	III,IV	1.000	0.273	.045	6	view →
ESCA	DFS	Tertile	III,IV	1.000	0.292	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MTND1P33–READ (DFS)

Open the READ breakdown →